NCT00770861

A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients

A Multicenter, Prospective, Randomized, Double-blind, Placebo-Controlled, Dose-Titration Study of Nebivolol Monotherapy in Hispanic Patients With Stage 1 or Stage 2 Hypertension

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 277 (actual)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the efficacy and safety of nebivolol monotherapy in Hispanic patients with stage 1 or stage 2 hypertension

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Nebivolol	Nebivolol 5 mg, 5-mg Nebivolol nontrade tablets , oral administration Nebivolol 10 mg, 10-mg Nebivolol nontrade tablets , oral administration Nebivolol 20 mg, 20-mg Nebivolol nontrade tablets , oral administration Nebivolol 40 mg, two 20-mg Nebivolol nontrade tablets , oral administration
DRUG	Placebo	Matching placebo tablets, oral administration

Timeline

• Start date: 2008-09-01
• Primary completion: 2009-11-01
• First posted: 2008-10-10
• Last updated: 2011-01-26
• Results posted: 2011-01-26

Locations

32 sites across 2 countries: United States, Puerto Rico